Evidence map›Paper›PMID 41303036›Full record

ReviewJournal of clinical medicine2025

Effects of Sodium Glucose Co-Transporter 2 Inhibitors on Atrial Fibrillation Recurrences After Catheter Ablation in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis.

Saketh Parsi, Kunal Sonavane, Usha Ravi, Pallavi D Shirsat, Venkata S Chamarthi, Mohamed Gabr, Harikrishna Choudary Ponnam, Salim Surani, Vikas Bansal, Rahul Kashyap

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Saketh ParsiDepartment of Internal Medicine, Ascension Seton Medical Center Austin, Austin, TX 78705, USA.ORCID 0009-0000-6721-6875
Kunal SonavaneDepartment of Internal Medicine, Willis Knighton Health, Bossier City, LA 71111, USA.ORCID 0009-0005-1402-4876
Usha RaviDepartment of Pediatrics, Pediatric Associates, Visalia, CA 93277, USA.ORCID 0009-0006-5277-0287
Pallavi D ShirsatDepartment of Nephrology, Minden Medical Center, Minden, LA 71055, USA.ORCID 0000-0003-4969-3488
Venkata S ChamarthiDepartment of Pediatrics, Valley Children's Healthcare, Fresno, CA 93720, USA.ORCID 0009-0008-2610-0946
Mohamed GabrCardiac Arrhythmia Service, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Harikrishna Choudary PonnamDepartment of Internal Medicine, Summa Health System, Akron, OH 44304, USA.ORCID 0009-0002-7007-2838
Salim SuraniDepartment of Medicine & Pharmacology, Texas A & M, College Station, TX 77840, USA.ORCID 0000-0001-7105-4266
Vikas BansalDepartment of Research, WellSpan Health, York, PA 17403, USA.ORCID 0000-0001-6047-5559
Rahul KashyapDepartment of Research, WellSpan Health, York, PA 17403, USA.ORCID 0000-0002-4383-3411

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ablationatrial fibrillationatrial fibrillation recurrencecardiac remodelingsodium glucose co-transporter 2 inhibitor

Identifiers

PMID41303036
PMCPMC12653339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.